24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

EMPAG Posters<br />

their own home .<br />

It emerged from the analysis that different approaches were taken by<br />

participating parents before they reached a reproductive decision, and<br />

while several factors influenced this, the first diagnosis <strong>of</strong> CF in the<br />

family had a particularly significant influence. Parents in this study appeared<br />

to have undergone an adaptation process during which they<br />

overcame the initial shock <strong>of</strong> a CF diagnosis in their child, developed<br />

a more positive outlook based largely on their own experiences <strong>of</strong> CF,<br />

and then felt able to address further reproductive decisions . However,<br />

following adaptation, some differences between the sexes emerged .<br />

Women frequently acknowledged that the decisions remained fluid<br />

and dynamic, whereas men tended to portray a more rigid standpoint<br />

once a particular decision had been reached . Furthermore, men and<br />

women <strong>of</strong>ten felt that they had inherently different roles in reproductive<br />

decision making, with the ultimate decision resting with the woman . In<br />

most cases, couples felt that the decision was made together, without<br />

significant external influence.<br />

EP01.06<br />

Uptake <strong>of</strong> genetic counselling and prenatal diagnostic services<br />

for cF in ireland<br />

D. M. Lambert1,2 , M. Morgan1 , S. Lynch2 ;<br />

1 2 Children’s Univeristy Hospital, Dublin, Ireland, National Centre for Medical<br />

<strong>Genetics</strong>, Dublin, Ireland.<br />

Cystic fibrosis (CF) is a common recessive condition in Ireland with 1<br />

in 19 carriers and 1 in 1440 affected . From January 2004 to July 2007,<br />

76 patients were sent appointments for genetic counseling for CF: 23<br />

(30%) were routine referrals from the CF clinic for a new CF family;<br />

and 53 (70%) were GP referrals for positive family history .<br />

For GP referrals the risk <strong>of</strong> being a CF carrier was: CF affected (3 .7%),<br />

known carrier (20 .7%), 2/3 risk (22 .6%), ½ risk (41 .5%), ¼ risk (7 .5%),<br />

population risk (1 .9%) . 66% had a partner while 34% wanted to discuss<br />

carrier status before finding a partner. Those at higher risk <strong>of</strong><br />

being a carrier were more likely to wait until they had a partner before<br />

being referred . Five <strong>of</strong> 53 (9%) were found to be at a 1 in 4 risk <strong>of</strong> CF .<br />

Of 25 families with a child with CF, 21 <strong>of</strong> the 23 referred attended the<br />

genetics appointment . Of the 30 families at 1 in 4 risk <strong>of</strong> CF, 15 (50%)<br />

remained childless since . For 26 <strong>of</strong> 30 couples a molecular prenatal<br />

diagnosis was available, with 12 having a pregnancy and 5 (42%) a<br />

prenatal test . 4 indicated interest in pre-implantation genetic diagnosis<br />

(PGD) . 6 families (20%) had members seen for cascade screening although<br />

the <strong>of</strong>fer was made to all . The uptake for prenatal diagnosis and<br />

screening <strong>of</strong> family members is lower than other <strong>European</strong> countries,<br />

perhaps reflecting the illegality <strong>of</strong> termination and PGD in Ireland.<br />

EP01.07<br />

Reproductive decision making in cF carrier couples; an<br />

explorative study in couples without an affected child<br />

J. Myring 1 , R. Sayers 2 , T. Roberts 3 , D. Scotcher 3 , M. McAllister 4,3 ;<br />

1 Clinical <strong>Genetics</strong>, NHS Tayside, Dundee, United Kingdom, 2 Sheffield Clinical<br />

<strong>Genetics</strong> Service, Sheffield Children’s NHS Foundation Trust, Sheffield, United<br />

Kingdom, 3 Regional <strong>Genetics</strong> Service and Medical <strong>Genetics</strong> Research Group,<br />

CMMC NHS Trust and University <strong>of</strong> Manchester, Manchester, United Kingdom,<br />

4 Nowgen (A Centre for Genetic Healthcare), Manchester, United Kingdom.<br />

We report on part <strong>of</strong> a larger research project which uses qualitative<br />

methodology to explore the reproductive decision making process in<br />

CF carrier couples . 5 males and 7 females from CF carrier couples<br />

without an affected child were interviewed individually in their home, to<br />

explore both male and female perspectives <strong>of</strong> the reproductive decision<br />

making process .<br />

Data analysis revealed that while couples may consider different scenarios,<br />

the decision making process remains largely unstructured . Personal<br />

experiences <strong>of</strong> CF were an important factor: Individuals had to<br />

weigh up their perception <strong>of</strong> the physical difficulties <strong>of</strong> CF, the fact that<br />

CF is not an intellectually disabling condition, and their attachment to<br />

someone with CF . Individuals may not fully engage with their risk <strong>of</strong><br />

having a child with CF during the decision making process, which may<br />

lead them to be unprepared for bad news .<br />

Men and women may play different roles within the reproductive decision<br />

making process . Men appeared to take on a supportive role, tending<br />

to agree with their partner . Women felt that the decision was mutual<br />

and intuitive, possibly due to this support from their partner . Both<br />

partners felt that ultimately, the decision was primarily the woman’s;<br />

influenced by the physical attachment to pregnancy and possibly their<br />

role as primary carer .<br />

CF carrier couples who have a healthy child in their first at-risk pregnancy<br />

may feel that they have “used up their luck”, which may lead to<br />

a decision to limit family size .<br />

EP01.08<br />

Ancestry-based preconceptional cF and HbPs carrier screening<br />

in a multi-ethnic population: attitude and participation,<br />

psychological outcomes, reproductive intentions and<br />

satisfaction<br />

P. Lakeman, A. M. C. Plass, L. Henneman, P. D. Bezemer, M. C. Cornel, L. P.<br />

ten Kate;<br />

VU University Medical Center, Amsterdam, The Netherlands.<br />

Objective: to investigate attitude and participation, psychological outcomes,<br />

reproductive intentions and satisfaction in ancestry-based preconceptional<br />

carrier screening for cystic fibrosis (CF) and hemoglobinopathies<br />

(HbPs) .<br />

Methods: 9,453 individuals were <strong>of</strong>fered carrier-testing, which was<br />

conditional on survey-participation . Eligible for test-participation were<br />

invitees who were planning a pregnancy with their partner . Both partners’<br />

ancestry determined eligibility for the CF and/or HbP-test(s) . Data<br />

were gathered with structured questionnaires, one <strong>of</strong> which was based<br />

on the Theory <strong>of</strong> Planned Behaviour, among 418 invitees <strong>of</strong> whom 247<br />

refrained from testing and 171 intended to participate in the testing,<br />

but <strong>of</strong> whom 143 actually did . Non-Western participants (n= 46) were<br />

under-represented .<br />

Results: All survey-participants, Western and non-Western, had a<br />

positive attitude towards test-participation . Among those who refrained<br />

from test-participation, 68% would participate in this kind <strong>of</strong> screening<br />

in the future if it became possible . Time and effort needed for participation<br />

were important declining factors . The majority reported no<br />

predominant feelings <strong>of</strong> stigmatization . More non-Western (23%) than<br />

Western participants (10%) thought that there would be discrimination<br />

against carriers . In general, the test-participants reported low levels<br />

<strong>of</strong> anxiety, intended to draw reproductive decisions from test-results,<br />

were satisfied and none <strong>of</strong> them regretted participation.<br />

Conclusion: Ancestry-based preconceptional CF and HbPs carrier<br />

screening was evaluated as positive and desirable among Western<br />

and non-Western participants . No major adverse psychological outcomes<br />

were reported . The effort and time needed for participation was<br />

an important reason for declining participation, which might be overcome<br />

by facilitating access to the screening .<br />

EP01.09<br />

Recruiting for reproductive choices<br />

S. Karner 1 , B. Wieser 1 , W. Berger 2 ;<br />

1 IFZ, Graz, Austria, 2 IFF, Klagenfurt, Austria.<br />

Prenatal testing has become a routine practice <strong>of</strong> antenatal care .<br />

According to international standards informed consent is a requirement<br />

prior to testing . However, due to the introduction <strong>of</strong> non-invasive<br />

screening (nuchal translucency measurement and the combined maternal<br />

blood test), this arrangement is undermined in some important<br />

ways. There is a tendency that counselling starts not before the first<br />

screening, but only if the results are conspicuous .<br />

In Austria antenatal care is organised in a comprehensive programme<br />

that is mandatory for all pregnant women . The aim <strong>of</strong> this programme<br />

is to secure the wellbeing <strong>of</strong> both the mother and her child . We argue<br />

that because <strong>of</strong> the contextualisation <strong>of</strong> non-invasive screening into<br />

the routine antenatal care it is difficult for pregnant women to distinguish<br />

between mandatory and elective examinations <strong>of</strong> antenatal care .<br />

This is especially relevant for the quality <strong>of</strong> informed consent that can<br />

be achieved in prenatal screening and subsequent diagnostic testing<br />

<strong>of</strong> the foetus .<br />

The presented case addresses recruiting processes for prenatal testing<br />

and subsequent reproductive choices . We will present data which<br />

show how non-invasive screening has significantly changed prenatal<br />

testing in Austria . From 2002 on there is a sharp increase in diagnosed<br />

cases per tested pregnant woman . The current abortion rate <strong>of</strong><br />

Down’s syndrome foetuses is about 94% . The remaining 6% include<br />

those who screened false-negative, decided against screening or testing,<br />

and those who decided not to terminate the pregnancy .

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!